Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$12.75−0.40 (-3.04%)
Close on Nov 16, 2026Market cap $86.56MP/E –Yield –
Eloxx Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Eloxx Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2012 was -2705.8%. For fiscal 2024 it was -38.8%, against -5019.9% the year before. The highest annual figure on record is -38.8% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -38.8% | +4981.1 |
| FY2014 | Jun 30, 2014 | -5019.9% | +54457.0 |
| FY2013 | Jun 30, 2013 | -59476.9% | −56771.2 |
| FY2012 | Jun 30, 2012 | -2705.8% | +756.0 |
| FY2010 | Jun 30, 2010 | -3461.8% | – |
See a number that looks wrong?